Skip to main content
. 2022 Jul 11;79(8):415. doi: 10.1007/s00018-022-04432-w

Table 1.

Blood–brain barrier ABC transporters and their major substrates relevant in pregnancy and neonatal life

Class Substrate ABC transporter(s) Relevance in pregnancy and neonatal life References
Anti-epileptic Phenobarbital P-gp First-line treatment for most neonatal seizures [39, 40]
Lamotrigine P-gp Safe for use during pregnancy (26,416,395) [39, 41]
Phenytoin

P-gp

Mrp1

Second line treatment for neonatal seizures [39, 40, 42]
Topiramate P-gp Second-generation AED, sometimes used to treat refractory neonatal seizures (Sandoval 2019) [39, 40]
Anti-HIV Zidovudine

P-gp

BCRP

Mrp4

Indicated for treatment of neonates with HIV [43, 44]
Ritonavir

P-gp

Mrp1, Mrp2

Infants and children, combined with Lopinavir [42, 45]
AZT

BCRP

Mrp4

Safe for use in pregnant women and their infants in combination w/Zidovudine [42, 46]
Analgesics Morphine P-gp Management for post-operative pain [39, 47]
Methadone P-gp Neonatal abstinence syndrome; therapeutic treatment for opiate abuse during pregnancy [47, 48]
Anti-cancer Doxorubicine

P-gp

BCRP

Mrp1, Mrp2, Mrp6

[42]
Mitoxantrone

P-gp

BCRP

[42]
Daunorubicin

P-gp

BCRP

Mrp1, Mrp6

[42]
Methotrexate

P-gp

Mrp1, Mrp2, Mrp3, Mrp4

[42]
Anti-depresssants Amitryptiline P-gp Increased rate of cardiac abnormalities when taken during pregnancy [42, 49]
Doxepin P-gp No increased incidence of neonatal cardiac abnormalities when used during pregnancy [42, 49]
Other substrates Verapamil

P-gp

Mrp1

Calcium channel blocker; a competitive inhibitor of P-gp [42]
Cyclosporin A

P-gp

Mrp1

Immunosuppressants; also a competitive inhibitor of P-gp [42]